Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
HELSINN HEALTHCARE S.A. et al v. DR. REDDY'S LABORATORIES, LTD. et al
Case Number:
3:12-cv-02867
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
February 15, 2017
Dr. Reddy's Generic Infringes Aloxi Patents, Judge Rules
A New Jersey federal judge on Wednesday found that Dr. Reddy's Laboratories Inc.'s planned generic version of Helsinn Healthcare SA's anti-nausea drug Aloxi infringes three patents for the drug and rejected Dr. Reddy's contention that two of those patents are invalid.
-
May 14, 2012
Roche, Helsinn Sue Dr. Reddy's Over Bid For Generic Aloxi
Roche Palo Alto LLC and Helsinn Healthcare SA on Friday hit Dr. Reddy's Laboratories Ltd. with a patent infringement suit challenging the rival drugmaker's attempt to get U.S. approval of a generic version of their anti-nausea medication Aloxi.